BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37380106)

  • 21. An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease.
    Lee E; Korf H; Vidal-Puig A
    J Hepatol; 2023 May; 78(5):1048-1062. PubMed ID: 36740049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non-alcoholic fatty liver disease.
    Wu CL; Zhao SP; Yu BL
    Biol Rev Camb Philos Soc; 2015 May; 90(2):367-76. PubMed ID: 24834836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can NASH lipidome provide insight into the pathogenesis of obesity-related non-alcoholic fatty liver disease?
    Birerdinc A; Younossi Z
    J Hepatol; 2015 Apr; 62(4):761-2. PubMed ID: 25602593
    [No Abstract]   [Full Text] [Related]  

  • 24. Chinese Medicinal Herbs Targeting the Gut-Liver Axis and Adipose Tissue-Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science.
    Zhang S; Wong YT; Tang KY; Kwan HY; Su T
    Front Endocrinol (Lausanne); 2020; 11():572729. PubMed ID: 33101207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
    Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
    Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
    Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
    Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology.
    Zhao J; Lei H; Wang T; Xiong X
    Front Endocrinol (Lausanne); 2023; 14():1161402. PubMed ID: 36967758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease.
    Pafili K; Kahl S; Mastrototaro L; Strassburger K; Pesta D; Herder C; Pützer J; Dewidar B; Hendlinger M; Granata C; Saatmann N; Yavas A; Gancheva S; Heilmann G; Esposito I; Schlensak M; Roden M
    J Hepatol; 2022 Dec; 77(6):1504-1514. PubMed ID: 35988689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex Differences in Nonalcoholic Fatty Liver Disease: Estrogen Influence on the Liver-Adipose Tissue Crosstalk.
    Morán-Costoya A; Proenza AM; Gianotti M; Lladó I; Valle A
    Antioxid Redox Signal; 2021 Sep; 35(9):753-774. PubMed ID: 33736456
    [No Abstract]   [Full Text] [Related]  

  • 30. Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients.
    Wree A; Schlattjan M; Bechmann LP; Claudel T; Sowa JP; Stojakovic T; Scharnagl H; Köfeler H; Baba HA; Gerken G; Feldstein AE; Trauner M; Canbay A
    Metabolism; 2014 Dec; 63(12):1542-52. PubMed ID: 25267016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenteric adipose tissue B lymphocytes promote local and hepatic inflammation in non-alcoholic fatty liver disease mice.
    Wu Z; Xu J; Tan J; Song Y; Liu L; Zhang F; Zhang Y; Li X; Chi Y; Liu Y
    J Cell Mol Med; 2019 May; 23(5):3375-3385. PubMed ID: 30772951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults.
    Wei Y; Liu J; Wang G; Wang Y
    Biol Sex Differ; 2023 Oct; 14(1):69. PubMed ID: 37814297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic drivers of non-alcoholic fatty liver disease.
    Bence KK; Birnbaum MJ
    Mol Metab; 2021 Aug; 50():101143. PubMed ID: 33346069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
    Milić S; Lulić D; Štimac D
    World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
    Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
    JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipose tissue macrophage dysfunction is associated with a breach of vascular integrity in NASH.
    Boesch M; Lindhorst A; Feio-Azevedo R; Brescia P; Silvestri A; Lannoo M; Deleus E; Jaekers J; Topal H; Topal B; Ostyn T; Wallays M; Smets L; Van Melkebeke L; Härtlova A; Roskams T; Bedossa P; Verbeek J; Govaere O; Francque S; Sifrim A; Voet T; Rescigno M; Gericke M; Korf H; van der Merwe S
    J Hepatol; 2024 Mar; 80(3):397-408. PubMed ID: 37977244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study.
    Oscarsson J; Önnerhag K; Risérus U; Sundén M; Johansson L; Jansson PA; Moris L; Nilsson PM; Eriksson JW; Lind L
    J Clin Lipidol; 2018; 12(6):1390-1403.e4. PubMed ID: 30197273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block.
    Musso G
    Endocrine; 2012 Oct; 42(2):237-9. PubMed ID: 22801991
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH).
    Jha P; Knopf A; Koefeler H; Mueller M; Lackner C; Hoefler G; Claudel T; Trauner M
    Biochim Biophys Acta; 2014 Jul; 1842(7):959-70. PubMed ID: 24594481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Palmitoleic Acid Decreases Non-alcoholic Hepatic Steatosis and Increases Lipogenesis and Fatty Acid Oxidation in Adipose Tissue From Obese Mice.
    Cruz MM; Simão JJ; de Sá RDCC; Farias TSM; da Silva VS; Abdala F; Antraco VJ; Armelin-Correa L; Alonso-Vale MIC
    Front Endocrinol (Lausanne); 2020; 11():537061. PubMed ID: 33117273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.